#Lutetium Therapy in India | Explore Tumblr Posts and Blogs

kims-trivandrum · 1 year

Text

Best Nuclear Medicine Treatment in Trivandrum, India | KIMSHEALTH Hospital

Nuclear medicine is a medical specialty involving the application of radioactive substances in the diagnosis and treatment of disease

Procedures & Treatments

Nuclear medicine, in a sense, is “radiology done inside out” or “endoradiology” because it records radiation emitting from within the body rather than radiation that is generated by external sources like X-rays. In addition, nuclear medicine scans differ from radiology as the emphasis is not on imaging anatomy but the function and for such reason, it is called a physiological imaging modality.

Single Photon Emission Computed Tomography or SPECT and Positron Emission Tomography or PET scans are the two most common imaging modalities in nuclear medicine

HEART:

Myocardial viability PET and SPECT

Adenosine Stress perfusion scan

Stress Dobutamine Myocardial MIBI perfusion SPECT

Stress and Rest myocardial perfusion SPECT

MUGA scan

BRAIN:

FDG brain PET CT

F-18 DOPA PET CT

Brain perfusion SPECT

Ictal and interIctal SPECT

Trodat SPECT

Tumour Viability Study

SKELETAL SYSTEM:

Three Phase Bone scan

Whole body Bone scan

F18 Fluoride Bone PET CT.

FDG PET prosthesis/infection Imaging.

Graft viability imaging

GASTROINTESTINAL:

Salivary scan

GE Reflux scan

Gastric Emptying Time

RBC — GI Bleed scan

Meckel’s scan

Whole body DOTA PET CT

HEPATOBILIARY/LIVER — SPLEEN:

Liver Spleen scan

RBC Blood pool scan

Hepatobiliary (HIDA) scan

MAA Sunt

GENITOURINARY:

Diuretic DTPA Renal scan

GFR Estimation

EC Renal scan (ERPF)

DMSA Cortical Renal scan

Captopril Renal scan

VU Reflux study

Renal Transplant study

Lymphoscintigraphy for Chyluria

Whole body PSMA PET CT

ENDOCRINE:

Technetium Thyroid scan

MIBI Thyroid scan

MIBI Parathyroid Scan

MIBG scan

Octreotide SPECT CT

ONCOLOGY:

Whole body FDG PET CT

Whole body Gallium 68 DOTA scan

Whole body Gallium 68 PSMA scan

F-18 Choline PET CT

Whole body iodine scan

Post therapy scan

F-18 DOPA PET CT

Senthinal lymphoscintrigrapy

Scintimammography

HSA scan for protein leak

INFECTION IMAGING:

Whole body FDG PET infection Imaging

Gallium 67 scan

99mTc Ubiquicidin Imaging

RESPIRATORY:

Lung Perfusion Scan

Ventilation — Perfusion (V/Q) scan

Quantitative lung ventilation

Mucociliary clearance study

Ventilation

BLOOD:

Lymphoscintigraphy for Lymphoedema.

Sentinel Node Mapping

RADIONUCLIDE THERAPY:

Radio lodine treatment for Thyrotoxicosis ( < 10 mci)

Radio lodine treatment for Thyrotoxicosis ( > 10 mci)

Radioiodine therapy for Ca. Thyroid ( <100 mci )

Radioiodine therapy for Ca. Thyroid ( >100 mci )

rTSH Radioiodine therapy for Ca thyroid

177 Lutetium DOTA therapy for Neuroendocrine tumors.

177 Lutetium PSMA therapy for Ca. Prostate

Samarium Skeletal Pain Palliative Therapy

90 Yttrium Radiation Synovectomy.

131 Iodine Lipidiol TARE therapy for HCC.

90 Yttrium Lipidiol TARE therapy

Strontium 89 skeletal pain palliative therapy

PET SCAN (OUTSIDE ) REVIEW

CT CONTRAST (PET CT)

omnipaque

visipaque

oral contrast (PET CT)

RBC BLOOD POOL

F CHOLINE

#Best Nuclear Medicine #Kims Nuclear Medicine #Kimshealth Trivandrum #Kimshealth Hospital

0 notes

alafiyameditourindia · 2 years

Link

1 note · View note

megasddw-blog · 5 years

Text

Radiopharmaceuticals Market Outlook and Forecast 2023: Growth Factors, Trends, and Top Companies Analysis for Business Development

MRFR is the Leading Brand in The Research Company who Recently Published Global Radiopharmaceuticals Market Research Reports which includes Study of Growth, Regional Overview, Top participants, Major Drivers and Forecast to 2023.

Radiopharmaceuticals Market - Overview

Global Radiopharmaceuticals Market to grow at a solid CAGR of 8.7% over the 2017-2023 forecast period due to the growing demand for radiopharmaceuticals in diagnostic as well as therapeutic applications in the healthcare sector.

As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Industry Updates:

In Q3 2018, Novartis (Advanced Accelerator Applications) acquired two new radioisotope drugs – Lu-PSMA-617 from Endocyte and FF-10158 from Fujifilm Toyama Chemical.

Competitive Players:

Leading players in the global radiopharmaceuticals market include Jubilant Life Sciences Ltd., Sun Pharmaceutical Industries Ltd., Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications SA (owned by Novartis), Nordion Inc., Bracco Diagnostic Inc., Avid Radiopharmaceuticals, IBA Dosimetry GmbH, Canadian Nuclear Laboratories, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Medtronic, Bayer AG, and Siemens AG.

In a similar manner as X-rays, these radioisotopes help physicians diagnose a number of diseases. In contrast, radioisotopes that emit short-range particles such as alpha and beta particles are used in therapeutic applications, as short-range particles “burn up”, i.e. lose their energy, over relatively short distances, allowing spectacular results in terms of cell destruction on a highly local scale. Radioisotopes of the latter kind also stay for longer periods of time in the human body, allowing for prolonged treatment.

The growing prevalence of cancer is the primary driver for the global radiopharmaceuticals market, as cancer treatment accounts for the majority of the application of radiopharmaceuticals in the healthcare sector. Growing investment in cancer research in a number of countries round the world is likely to remain a major driver for the radiopharmaceuticals market over the forecast period, as many countries have started to take the threat of cancer seriously following a steady rise in the prevalence of many cancer types. On the other hand, the high cost of radiopharmaceuticals and the risks of using radiopharmaceuticals in therapeutic applications are likely to hamper the growth prospects of the global radiopharmaceuticals market over the forecast period.

Segmentation Analysis:

The global radiopharmaceutical market is segmented based on type, type of test, application, route of administration, end user, and region.

By type, the market for radiopharmaceuticals is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostics segment is further sub-segmented into SPECT radiopharmaceuticals and PET radiopharmaceuticals; the SPECT radiopharmaceuticals segment is further sub-segmented into technetium-99m, thallium-201, iodine-123, and others, while The PET radiopharmaceuticals segment is further sub-segmented into F-18, rubidium-82, and others.

The therapeutic radiopharmaceuticals segment is further sub-segmented into beta emitters, alpha emitters, and brachytherapy. The beta emitters segment is further sub-segmented into iodine-131, yttrium-90, samarium-153, rhenium-186, lutetium-177, and others. The brachytherapy segment is sub-segmented into iodine-125, iridium-192, cesium-131, and others.

Browse Complete 271 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

By type of test, the market is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan, and others. The myocardial perfusion scan segment is further sub-segmented into technetium-99m, thallium-201, rubidium-82, and others. The lung scan segment is further sub-segmented into xenon-133, krypton-81m, and others. The bone scan segment is further sub-segmented into technetium-99m, fluoride-18, and others. The white blood cell scan segment is sub-segmented into indium-111 and others.

By application, the market is segmented into oncology, cardiology, neurology, urology, and others. The oncology segment is further segmented into prostate cancer, bone cancer, breast cancer, and others. The cardiology segment is further segmented into coronary artery disease, cardiomyopathy, and others. The neurology segment is further segmented into traumatic brain injury, stroke, Alzheimer’s disease, and others. The urology segment is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the market is segmented into oral, intravenous, and others.

By end user, the market is segmented into hospitals, diagnostic centers, research institutes, and others.

Regional Analysis:

The global radiopharmaceuticals market is segmented by geography into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is the dominant regional segment of the global radiopharmaceuticals market and is likely to remain the leading contributor to the global market due to the high prevalence of cancer as well as other neurological and cardiovascular diseases in which radiopharmaceuticals are used in some capacity. The increasing investment in cancer research in the Americas, particularly the U.S., is likely to be a major driver for the radiopharmaceuticals market in the region over the forecast period.

Moreover, Asia Pacific is likely to be the fastest growing regional market due to the growing prevalence of cancer and the growing awareness about SPECT and PET systems.

Major TOC of Radiopharmaceutical Market Research Report – Forecast to 2023:

1 Report Prologue

2 Executive Summary

3 Market Introduction

4 Research Methodology

5 Market Dynamics

6 Market Factor Analysis

TOC CONTINUED…

List of Tables:

TABLE 1 MARKET SYNOPSIS 25

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014–2023 (USD MILLION) 48

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 5 GLOBAL RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 6 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 7 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 8 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014–2023 (USD MILLION) 51

TABLE 9 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

TABLE 10 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

LOT CONTIONUED…!

To know more Updates Related Report Visit at https://www.openpr.com/news/1115880/Radiopharmaceutical-Market-2018-Renowned-Players-like-Siemens-Sun-Pharmaceutical-Industries-Cardinal-Health-Medtronic-etc-by-2023.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

0 notes

sumitchoudhari-blog · 5 years

Text

Radio Pharmaceutical Market by Technology & End-User - 2023 | Market Research Future

The global radiopharmaceutical market is expected to grow at a CAGR of 8.7% during the forecast period 2017–2023. The market’s growth is mainly attributed to the increasing prevalence of chronic diseases, which is creating a greater need for early diagnosis and treatment modules.

Intended Audience

· Drugs & Medical Device Manufacturers for radiopharmaceutical

· Drugs& Medical Device Suppliers for radiopharmaceutical

· Training & Service providers for radiopharmaceutical

· Research and Development (R&D) Companies

· Market Research and Consulting Service Providers

· Potential Investors

Radio Pharmaceutical Market Segmentation:

The global radiopharmaceutical market is segmented by type, type of test, application, route of administration, and end user.

By type, it is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. Diagnostic type radiopharmaceutical is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. Therapeutic type radiopharmaceutical is further sub-segmented into beta emitters, alpha emitters, brachytherapy. SPECT radiopharmaceutical is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. PET radiopharmaceutical is further sub-segmented into F-18, Rubidium-82, and others. While, beta emitters are sub-segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. And, brachytherapy is sub-segmented into Iodine-125, Iridium-192, Cesium-131, and others.

By type of test, it is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan and others. Whereas, a bone scan is further sub-segmented into Technetium-99m 1st, fluoride-18 2nd, and others. Myocardial Perfusion Scan, Type is sub-segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan by type is segmented into Xenon-133, Krypton-81m, and others. And, White blood cell Scan is sub-segmented into Indium-111 and others.

By application, it is segmented into oncology, cardiology, neurology, urology, and others. Oncology segment is further segmented into following applications; prostate cancer, bone cancer, breast cancer and others. Cardiology segment is further segmented into following applications; coronary artery disease, cardiomyopathy and others. Neurology segment is further segmented into following applications such as traumatic brain injury, stroke, Alzheimer’s disease and others. Urology is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1650

Key Players

Some of the key players in this market are Jubilant Life Sciences Ltd., Siemens AG, Sun Pharmaceutical Industries Ltd., Bayer AG, Cardinal Health Inc., Medtronic, General Electric Company (GE Healthcare), Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., Mallinckrodt Pharmaceuticals, Nordion, Inc., Canadian Nuclear Laboratories (CNL), Bracco Diagnostic Inc., IBA Dosimetry GmbH, Avid Radiopharmaceuticals and few others.

The report offers insights on the prominent market players and gauges their current position in the market. Company information with regard to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives.

Regional Analysis

The global radiopharmaceutical market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa. Among these, Americas and Europe will continue to present lucrative growth opportunities for market players during the forecast period. Currently, these two regions collectively account for the largest share of the market and the trend is likely to continue over the next couple of years. Higher healthcare spending and existence a robust healthcare system system in these regions is reflecting favorably on the market. In Asia Pacific, increased focus on improving the quality of healthcare services is auguring well for market players operating in the region. During the review period, the market in the region is expected to capture a strong CAGR.

Table Of Content

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Scope Of Study 27

3.2 Research Objective 27

3.3 Assumptions & Limitations 27

3.3.1 Assumptions 27

3.3.2 Limitations 27

3.4 Market Structure 27

4 Research Methodology

4.1 Primary Research 29

4.2 Secondary Research 30

4.3 Market Size Estimation 31

4.4 Forecast Model 31

TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email:

[email protected]

#Healthcare

0 notes

nuclearmedicinetherapy · 8 months

Text

youtube

The Nuclear Medicine Therapy Centre at FMRI is one of the pioneers in medical tourism for patients with prostate cancer and neuroendocrine tumors. The center provides you with an effortless way to understand and go through your treatment process including pick-up/drop, and visa on arrival. We ensure that the treatment is effortless and budget-friendly and are there with you to help navigate everything.

#Lutetium Therapy #Lutetium Therapy in India #lutetium psma #Youtube

0 notes

marketerarena-blog · 5 years

Text

Americans Are Traveling Abroad for Medical Care. Here’s How it Could Save You Thousands

Three years ago, Justin Bull was goofing around with friends, swinging on a tree rope, when he lost his grip. The 29-year-old multi-sport athlete and dirt biker plunged 35 feet, landing on his right shoulder and snapping a tendon. Worse yet, he was uninsured, which meant getting surgery in his hometown of Fort Worth, Texas, would cost $40,000, all out-of-pocket.

“I was looking at going into serious debt,” he says.

Then Bull’s mother made a surprising suggestion: Go abroad to get it done. A few years before, she’d traveled to the Czech Republic for surgery on her ankle. The procedure had been top-notch, complication-free, and a huge cost-saver. Bull did some research and opted for the Hospitales Amerimed in Cancún, Mexico—an orthopedic-surgery destination for professional athletes worldwide. Bull was hesitant at first, but says ultimately it couldn’t have gone better.

“The surgeon was great at communicating,” he says. “We spoke twice before to Mexico.”

When he and a buddy arrived, they were picked up and taken to the hospital for Bull’s blood work and transported to a resort for a four-day, pre-op vacation. Total cost of airfare, a week in a resort for two, and all medical costs: $7,400. He checked with two U.S. surgeons afterward who said the work on his shoulder passed muster.

Plastic Surgery Is Skyrocketing Among Men: Here’s What Guys Are Getting Done

Bull’s experience is hardly unusual. So-called medical tourism—traveling outside the country for care—has become a substantial global industry. Many of these patients live in countries with subpar medical systems, and their destination is the U.S. But since American health care is more expensive than any other nation’s, more U.S. citizens—even those who have insurance—are going abroad for surgery, advanced treatments, and other types of health care.

The typical medical traveler is looking for a relatively minor, elective procedure that may not be fully covered by insurance. Data is spotty on how many Americans travel for care, but experts estimate it’s at least a few hundred thousand a year. And as the cost of domestic health care rises—and insurance excludes many types of treatments altogether—that number is likely to grow.

By all accounts, the quality and safety of overseas care can be excellent. Many foreign physicians were trained in the U.S. or Western Europe, reducing the language barrier. And they tend to specialize in one or two procedures, helping to ensure better outcomes. Outside of the operating room, meanwhile, the patient experience can be well above typical U.S. standards, with shorter waiting room times, longer pre- and post-op physician visits, and greater attention from the nursing staff. There’s also concierge-level assistance with travel arrangements and booking recuperative care at nearby hotels that cater to their recovering clientele. Once you get home, your foreign doctor will have sent medical records to a hometown physician for follow-ups.

How to Find the Right Doctor for You

This industry didn’t arise accidentally. Over the past decade, private hospitals have come to view medical tourists as a major profit center, treating them as valued customers who can boost their business with good word of mouth. Some national airlines have even discounted or subsidized fares for medical tourists. In Thailand and Malaysia, patients are greeted at airport-based hospital service centers and may start their treatment there. Some of the medical centers are advertised like resorts, boasting suites with bucolic views, concierge services, indoor pools, and fine dining.

Nonetheless, it takes a special kind of person to grab his passport and get surgery in a place he’s visiting for the first time. Josef Woodman, CEO of Patients Beyond Borders, a medical-travel advocacy group, says the prime new market is millennials, like Bull.

“A lot of them have sports injuries, which aren’t always covered by insurance,” Woodman says. “They like to travel, they don’t trust U.S. health care, and they love beating the system.”

This helps explain why one of the most common types of significant surgery sought by U.S. medical travelers is orthopedic, especially for knees and hips. Typically, these procedures are nonemergencies, require short hospital stays, and have low complication rates, making them well-suited for travelers. Main destinations for procedures like joint repairs and replacements include Mexico, Thailand, and India.

The Sick Cost of Medical Paperwork

Dentistry is the other big draw, accounting for about half of U.S. medical travel. Many patients head to Mexican border towns like Los Algodones, a 22-minute drive from Yuma, Arizona. The city has become devoted to the industry. Staffers in the dental clinics speak English, and local restaurants offer soft-food menus. That’s where Vincent Humphrey, a 32-year-old lawyer from Seattle, went to get $14,000 worth of long overdue dental work. He spent one heavily medicated week in Los Algodones and returned to Washington just $3,500 lighter. Two dentists back home who reviewed the work were impressed, Humphrey says. Going to Mexico for a root canal may not yet be front-of-mind. And medical tourism has had to shed its bad rap, primarily its association with botched plastic surgery. But quality and accountability have improved in that specialty, too. These days, countries including Costa Rica and Brazil are a draw for Americans seeking an aesthetic upgrade, and a growing number of them are middle-aged men.

“In Silicon Valley, if a 40-year-old guy shows up at a meeting, people ask who brought their grandfather,” Woodman says. “More men are getting work done, and are looking to travel to do it.” And being out of town is often a plus for cosmetic surgery patients, who’d just as soon hide out at a resort for a week or two until the telltale swelling and bruising goes away.

Travel for in vitro fertilization is also popular, with Greece a frequent destination.

“People travel as a couple, have the procedure, and then go sightseeing,” says Maria Kniazeva, a professor at the University of San Diego School of Business who studies medical tourism marketing. The cost savings for in vitro fertilization are substantial—about $3,500 in Greece compared with $15,000 to $18,000 at home.

Some medical travelers have such positive experiences that they become total converts. Take Kenneth Cunningham, a 58-year-old clinical social worker in Toledo, Ohio. When his physician reviewed Cunningham’s family history, which is rife with cancer, he called the situation “alarming” and ordered a colonoscopy and other tests. Cunningham had let his insurance lapse in the face of increasing premiums and learned the bill for a diagnostic workup would come to $10,000.

“People travel as a couple, have the procedure, and then go sightseeing”

That’s when his son, who lives in Budapest, suggested his father get the tests done there. Cunningham’s doctor in Hungary did her residency at Tulane Medical Center in New Orleans and was highly familiar with all of the cancers in his family.

“I wasn’t worried one stitch,” he says.

Cunningham says he was ferried to and from the “exquisite” hospital, given a thorough preoperative exam and battery of lab tests, and attended to by empathetic nurses.

“It was a much better patient experience in every way than I’ve ever had here,” he adds.

His total medical bill: $616.

Cunningham now plans to forgo U.S. insurance altogether and have all his medical needs taken care of overseas, from routine dental work all the way to significant procedures and treatment should the need arise.

While most medical travel is for non-urgent procedures, it sometimes makes sense for patients facing massive bills for more serious care, including heart surgery and cancer treatment. Both draw patients to India, where major surgery can be a fifth of the U.S. cost, and chemotherapy drugs a twentieth. Some of the most advanced radiation treatments for prostate cancer, such as proton-beam therapy, can run to $120,000 in the U.S. but average just $35,000 in South Korea. Major surgery may require a stay of several weeks, but some cancer treatments can be done over the course of a few days, with a return visit months later.

9 Health Statistics That Actually Matter—and When You Should Check Them

Certain types of promising and sophisticated new treatments can only be had overseas. Lutetium-177-PSMA therapy, a highly targeted prostate radiation procedure for late-stage cancer, is still in clinical trials in the U.S. but is routine at the Docrates Cancer Center in Helsinki. Given how many Americans now receive care abroad, insurance companies have started to respond. Travelers generally pay everything out of pocket, but it’s worth checking with your employer or insurance carrier to see if they will offer an incentive to get care abroad. In some cases, you could be saving the insurer thousands, and some companies are now willing to chip in—or even pay you to do it. BlueCross BlueShield of South Carolina and UnitedHealth Group already have insurance plans with medical travel options, and other carriers may follow suit.

As with any medical intervention, there are risks. Complications, such as infections, can arise no matter where a procedure gets done. But logistics get tricky if you’re in, say, Southeast Asia. Plus, surgery can go awry. That’s why experts recommend medical travel insurance, which pays for follow-up procedures to fix bad work, either in the country where it was originally done, or back in the U.S. Most patients opt for this coverage, which is why there are few stories of uninsured people who get strapped with a big bill to remedy a bungled surgery.

That extra layer of planning is one of the aspects that can be a turnoff. Plus, consider that international travel is stressful, as is having surgery. So imagine going to the Middle East for a major operation. Even if the logic behind the effort is unimpeachable (the quality is the same; the cost savings are significant), emotionally it may not be worth it. But for seasoned travelers, the trip could net a vacation financed entirely by the savings on astronomical health care costs in the U.S.

6 Secrets to Snagging a Last-minute Doctor’s Appointment

https://askfitness.today/americans-are-traveling-abroad-for-medical-care-heres-how-it-could-save-you-thousands/

#fitnessblog

0 notes